Frequency- and voltage-dependent effects of disopyramide in canine Purkinje fibers
- PMID: 2766102
- DOI: 10.1139/y89-115
Frequency- and voltage-dependent effects of disopyramide in canine Purkinje fibers
Abstract
The voltage- and frequency-dependent blocking actions of disopyramide were assessed in canine Purkinje fibers within the framework of concentrations, membrane potentials, and heart rates which have relevance to the therapeutic actions of this drug. Vmax was used to assess the magnitude of sodium channel block. Disopyramide produced a concentration- and rate-dependent increase in the magnitude and kinetics of Vmax depression. Effects on activation time (used as an estimate of drug effect on conduction) were exactly analogous to effects on Vmax. A concentration-dependent increase in tonic block was also observed. Despite significant increases in tonic block at more depolarized potentials, rate-dependent block increased only marginally with membrane potential over the range of potentials in which propagated action potentials occur. Increases in extracellular potassium concentration accentuated drug effect on Vmax but attenuated drug effect on action potential duration. Recovery from rate-dependent block followed two exponential processes with time constants of 689 +/- 535 ms and 15.7 +/- 2.7 s. The latter component represents dissociation of drug from its binding site and the former probably represents recovery from slow inactivation. A concentration-dependent increase in the amplitude of the first component suggested that disopyramide may promote slow inactivation. There was less than 5% recovery from block during intervals equivalent to clinical diastole. Thus, depression of beats of all degrees of prematurity was similar to that of basic drive beats. Prolongation of action potential duration by therapeutic concentrations of drug following a long quiescent interval was minimal. However, profound lengthening of action potential duration occurred following washout of drug effect at a time when Vmax depression had reverted to normal, suggesting that binding of disopyramide to potassium channels may not be readily reversed. Variable effects on action potential duration may thus be attributed to a block of the window current flowing during the action potential being partially or over balanced by block of potassium channels. Purkinje fiber refractoriness was prolonged in a frequency-dependent manner. Disopyramide did not significantly alter the effective refractory period of basic beats but did increase the effective refractory period of sequential tightly coupled extra stimuli. The results can account for the antiarrhythmic actions of disopyramide during a rapid tachycardia and prevention of its initiation by programmed electrical stimulation.
Similar articles
-
Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.J Pharmacol Exp Ther. 1990 Aug;254(2):603-11. J Pharmacol Exp Ther. 1990. PMID: 2166798
-
The electrophysiological effects of disopyramide phosphate on canine ventricular muscle and Purkinje fibers in normal and low potassium.Can J Physiol Pharmacol. 1978 Feb;56(1):139-49. doi: 10.1139/y78-018. Can J Physiol Pharmacol. 1978. PMID: 638850
-
Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.Circ Res. 1975 Dec;37(6):844-54. doi: 10.1161/01.res.37.6.844. Circ Res. 1975. PMID: 1192576
-
Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.Circulation. 1987 Aug;76(2):427-41. doi: 10.1161/01.cir.76.2.427. Circulation. 1987. PMID: 2440617
-
Stereospecific effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine.J Cardiovasc Pharmacol. 1987 Mar;9(3):276-84. doi: 10.1097/00005344-198703000-00003. J Cardiovasc Pharmacol. 1987. PMID: 2437393
Cited by
-
Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide.Cardiovasc Drugs Ther. 1991 Feb;5(1):139-46. doi: 10.1007/BF03029809. Cardiovasc Drugs Ther. 1991. PMID: 2036332
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources